Synopsis of recent research by authors named "Alen Zollo"
- Alen Zollo's recent research primarily focuses on the genetic factors influencing treatment responses in multiple sclerosis (MS) and the susceptibility to the disease, as evidenced by his work on pharmacogenomics related to Natalizumab and the identification of the TBKBP1 gene as a significant marker.
- His studies utilize genome-wide association analyses and multi-centre data to explore the genetic underpinnings of MS, indicating a substantial interest in addressing the "missing heritability" in MS susceptibility, as highlighted in his cohort study of Italian individuals.
- Additionally, Zollo is involved in researching Alzheimer's disease, investigating the role of the Amyloid Precursor Protein (APP) and its relationship with neurodegenerative processes, emphasizing the need for therapeutic strategies targeting these pathways.